Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Does The Use Of Blinatumomab Improve The Overall Survival Rate In Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia?, Julia Colangeli
Does The Use Of Blinatumomab Improve The Overall Survival Rate In Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia?, Julia Colangeli
PCOM Physician Assistant Studies Student Scholarship
Objective: The objective of this selective EBM review paper is to determine whether or not, “Does the use of blinatumomab improve the overall survival rate in adults with relapsed/refractory acute lymphoblastic leukemia?”
Study Design: A systematic review of two RCTs and one case-based series were utilized. All studies were published between 2014-2019.
Data Sources: The two RCTs were found through PubMed and the case-based series was obtained through CINAHL Plus. All the studies were published in peer-reviewed journals.
Outcomes Measured: The main outcome measured in all the studies was overall survival. Both RCTs defined overall survival as the time from …